弥漫性-话题@MedSci

#弥漫性#

118篇内容 | 2444人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1438650, encodeId=cd631438650ea, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=iFLT-PET/CT是弥漫性大B细胞淋巴瘤化疗免疫治疗后无进展生存率的早期和优越预测指标, objectType=article, longId=215050, objectId=6c75215050c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c75215050c9, replyNumber=0, likeNumber=73, createdTime=2021-07-31, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c75215050c9, moduleTitle=iFLT-PET/CT是弥漫性大B细胞淋巴瘤化疗免疫治疗后无进展生存率的早期和优越预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c75215050c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438649, encodeId=7f9a143864927, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=J Clin Invest：弥漫性中线胶质瘤的H3.3K27M特异性疫苗反应, objectType=article, longId=209922, objectId=9d43209922bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d43209922bc, replyNumber=0, likeNumber=75, createdTime=2021-04-15, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d43209922bc, moduleTitle=J Clin Invest：弥漫性中线胶质瘤的H3.3K27M特异性疫苗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d43209922bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438648, encodeId=2df01438648fc, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle= Clinical Nutrition: 25（OH）D的生物利用度与弥漫性大B细胞淋巴瘤患者的临床结局相关, objectType=article, longId=207556, objectId=3aa220e556bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aa220e556bc, replyNumber=0, likeNumber=98, createdTime=2021-02-26, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aa220e556bc, moduleTitle= Clinical Nutrition: 25（OH）D的生物利用度与弥漫性大B细胞淋巴瘤患者的临床结局相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aa220e556bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438647, encodeId=b4a6143864e1d, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Nat Commun：双重靶向多胺合成和摄取：弥漫性内生性脑桥胶质瘤的潜在治疗策略, objectType=article, longId=207126, objectId=eefc20e12631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eefc20e12631, replyNumber=0, likeNumber=61, createdTime=2021-02-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eefc20e12631, moduleTitle=Nat Commun：双重靶向多胺合成和摄取：弥漫性内生性脑桥胶质瘤的潜在治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eefc20e12631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438646, encodeId=6a80143864605, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=JCO：来那度胺联合R-CHOP治疗可延长未经治疗的弥漫性大B细胞淋巴瘤患者的生存期, objectType=article, longId=207011, objectId=dcad20e01104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcad20e01104, replyNumber=0, likeNumber=70, createdTime=2021-02-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcad20e01104, moduleTitle=JCO：来那度胺联合R-CHOP治疗可延长未经治疗的弥漫性大B细胞淋巴瘤患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcad20e01104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438645, encodeId=f78914386456b, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Acta Neuropathologica: 在一系列83例H3F3A K27M突变的弥漫性中线胶质瘤中，FGFR1突变与较好的预后相关 , objectType=article, longId=206259, objectId=280e2062593b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=280e2062593b, replyNumber=0, likeNumber=86, createdTime=2021-01-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=280e2062593b, moduleTitle=Acta Neuropathologica: 在一系列83例H3F3A K27M突变的弥漫性中线胶质瘤中，FGFR1突变与较好的预后相关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=280e2062593b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438644, encodeId=39ab143864415, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Clin Nutrition: 25（OH）D的生物利用度与弥漫性大B细胞淋巴瘤患者的临床结局相关, objectType=article, longId=205595, objectId=b9f020559582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9f020559582, replyNumber=0, likeNumber=91, createdTime=2021-01-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9f020559582, moduleTitle=Clin Nutrition: 25（OH）D的生物利用度与弥漫性大B细胞淋巴瘤患者的临床结局相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9f020559582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438643, encodeId=1cf7143864374, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Br J Cancer：药物RO6870810对NUT中线癌、其他实体瘤或弥漫性大B细胞淋巴瘤患者的治疗效果, objectType=article, longId=204967, objectId=9ede20496e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ede20496e6a, replyNumber=0, likeNumber=72, createdTime=2020-12-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ede20496e6a, moduleTitle=Br J Cancer：药物RO6870810对NUT中线癌、其他实体瘤或弥漫性大B细胞淋巴瘤患者的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ede20496e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438642, encodeId=906a1438642a3, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Nat Commun：IL6反式信号转导通路：弥漫性癌细胞转移的潜在机制, objectType=article, longId=202212, objectId=203720221290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=203720221290, replyNumber=0, likeNumber=83, createdTime=2020-10-18, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=203720221290, moduleTitle=Nat Commun：IL6反式信号转导通路：弥漫性癌细胞转移的潜在机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=203720221290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438641, encodeId=6a4b143864140, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=FDA授予Paxalisib治疗弥漫性内源性桥脑胶质瘤的罕见儿科疾病疗法称号（RPDD）, objectType=article, longId=198985, objectId=f8a7198985ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8a7198985ca, replyNumber=0, likeNumber=72, createdTime=2020-08-09, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8a7198985ca, moduleTitle=FDA授予Paxalisib治疗弥漫性内源性桥脑胶质瘤的罕见儿科疾病疗法称号（RPDD）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8a7198985ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438640, encodeId=6564143864073, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=急性弥漫性脑肿胀2例, objectType=article, longId=198926, objectId=ff461989261e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff461989261e, replyNumber=0, likeNumber=0, createdTime=2020-08-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff461989261e, moduleTitle=急性弥漫性脑肿胀2例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff461989261e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438639, encodeId=f1cd143863928, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=FDA批准Monjuvi（tafasitamab-cxix）联合来那度胺治疗复发难治弥漫性大B细胞淋巴瘤, objectType=article, longId=198654, objectId=e12d1986548a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e12d1986548a, replyNumber=0, likeNumber=40, createdTime=2020-08-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12d1986548a, moduleTitle=FDA批准Monjuvi（tafasitamab-cxix）联合来那度胺治疗复发难治弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e12d1986548a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438638, encodeId=06931438638ff, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=弥漫性子宫内膜息肉一例, objectType=article, longId=197991, objectId=82a419e991c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82a419e991c4, replyNumber=0, likeNumber=52, createdTime=2020-07-26, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82a419e991c4, moduleTitle=弥漫性子宫内膜息肉一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82a419e991c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438637, encodeId=f491143863e8f, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Acta Neuropathologica：一例COVID-19的青年人H3K27M突变型弥漫性脑胶质瘤伴随广泛的瘤内微血栓, objectType=article, longId=197738, objectId=dccc19e73871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dccc19e73871, replyNumber=0, likeNumber=66, createdTime=2020-07-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dccc19e73871, moduleTitle=Acta Neuropathologica：一例COVID-19的青年人H3K27M突变型弥漫性脑胶质瘤伴随广泛的瘤内微血栓, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dccc19e73871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438636, encodeId=485c1438636a3, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Clin cancer research：EPZ-6438联合R-CHOP治疗弥漫性大B细胞淋巴瘤, objectType=article, longId=197011, objectId=7c6419e01122, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c6419e01122, replyNumber=0, likeNumber=70, createdTime=2020-07-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c6419e01122, moduleTitle=Clin cancer research：EPZ-6438联合R-CHOP治疗弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c6419e01122)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438635, encodeId=e373143863571, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Arthritis Rheumatol：早期弥漫性皮肤SSc患者间质性肺病的肺功能检查, objectType=article, longId=196609, objectId=4f071966092f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f071966092f, replyNumber=0, likeNumber=62, createdTime=2020-06-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f071966092f, moduleTitle=Arthritis Rheumatol：早期弥漫性皮肤SSc患者间质性肺病的肺功能检查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f071966092f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438634, encodeId=a4571438634d3, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Lancet oncol：Tafasitamab联合来那度胺治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效, objectType=article, longId=195473, objectId=16a61954e3e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a61954e3e1, replyNumber=0, likeNumber=38, createdTime=2020-06-09, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a61954e3e1, moduleTitle=Lancet oncol：Tafasitamab联合来那度胺治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16a61954e3e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438633, encodeId=6fc1143863321, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=J Cell Physiol：弥漫性低级胶质瘤的肿瘤微环境中的免疫相关基因和免疫细胞浸润的研究报告, objectType=article, longId=194800, objectId=0a7f194800ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a7f194800ec, replyNumber=0, likeNumber=54, createdTime=2020-05-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a7f194800ec, moduleTitle=J Cell Physiol：弥漫性低级胶质瘤的肿瘤微环境中的免疫相关基因和免疫细胞浸润的研究报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a7f194800ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438632, encodeId=f62d143863262, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Crit Care：自身免疫性疾病相关的严重弥漫性肺泡出血, objectType=article, longId=194621, objectId=bd08194621da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd08194621da, replyNumber=0, likeNumber=117, createdTime=2020-05-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd08194621da, moduleTitle=Crit Care：自身免疫性疾病相关的严重弥漫性肺泡出血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd08194621da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438631, encodeId=909c1438631a3, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Brit J Heamatol：他汀类药物和环氧合酶2抑制剂可提高弥漫性大B细胞淋巴瘤患者的存活率, objectType=article, longId=193101, objectId=1e4d193101ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4d193101ba, replyNumber=0, likeNumber=119, createdTime=2020-04-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4d193101ba, moduleTitle=Brit J Heamatol：他汀类药物和环氧合酶2抑制剂可提高弥漫性大B细胞淋巴瘤患者的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4d193101ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

弥漫性

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

iFLT-PET/CT是弥漫性大B细胞淋巴瘤化疗免疫治疗后无进展生存率的早期和优越预测指标

2021-07-31

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

J Clin Invest：弥漫性中线胶质瘤的H3.3K27M特异性疫苗反应

2021-04-15

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Clinical Nutrition: 25（OH）D的生物利用度与弥漫性大B细胞淋巴瘤患者的临床结局相关

2021-02-26

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Nat Commun：双重靶向多胺合成和摄取：弥漫性内生性脑桥胶质瘤的潜在治疗策略

2021-02-16

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

JCO：来那度胺联合R-CHOP治疗可延长未经治疗的弥漫性大B细胞淋巴瘤患者的生存期

2021-02-11

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Acta Neuropathologica: 在一系列83例H3F3A K27M突变的弥漫性中线胶质瘤中，FGFR1突变与较好的预后相关

2021-01-27

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Clin Nutrition: 25（OH）D的生物利用度与弥漫性大B细胞淋巴瘤患者的临床结局相关

2021-01-12

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Br J Cancer：药物RO6870810对NUT中线癌、其他实体瘤或弥漫性大B细胞淋巴瘤患者的治疗效果

2020-12-30

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Nat Commun：IL6反式信号转导通路：弥漫性癌细胞转移的潜在机制

2020-10-18

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

FDA授予Paxalisib治疗弥漫性内源性桥脑胶质瘤的罕见儿科疾病疗法称号（RPDD）

2020-08-09

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

急性弥漫性脑肿胀2例

2020-08-08

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

FDA批准Monjuvi（tafasitamab-cxix）联合来那度胺治疗复发难治弥漫性大B细胞淋巴瘤

2020-08-05

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

弥漫性子宫内膜息肉一例

2020-07-26

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Acta Neuropathologica：一例COVID-19的青年人H3K27M突变型弥漫性脑胶质瘤伴随广泛的瘤内微血栓

2020-07-20

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Clin cancer research：EPZ-6438联合R-CHOP治疗弥漫性大B细胞淋巴瘤

2020-07-05

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Arthritis Rheumatol：早期弥漫性皮肤SSc患者间质性肺病的肺功能检查

2020-06-29

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Lancet oncol：Tafasitamab联合来那度胺治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效

2020-06-09

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

J Cell Physiol：弥漫性低级胶质瘤的肿瘤微环境中的免疫相关基因和免疫细胞浸润的研究报告

2020-05-28

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Crit Care：自身免疫性疾病相关的严重弥漫性肺泡出血

2020-05-24

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Brit J Heamatol：他汀类药物和环氧合酶2抑制剂可提高弥漫性大B细胞淋巴瘤患者的存活率

2020-04-30

科室
- - 订阅+
  - 更多科室
工具
服务